Multicenter, Double‐Blind, Randomized Trial of Emricasan in Hepatitis C–Treated Liver Transplant Recipients With Residual Fibrosis or Cirrhosis

Overview of attention for article published in Liver Transplantation, April 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (74th percentile)
Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

twitter: 12 X users

facebook: 1 Facebook page

Readers on

mendeley: 23 Mendeley

So far, Altmetric has seen 13 X posts from 12 X users, with an upper bound of 56,429 followers.

Multicenter, Double-Blind, Randomized Trial of Emricasan in Hepatitis C-Treated Liver Transplant Recipients With Residual Fibrosis or Cirrhosis https://t.co/X0zFDwVQXK

RT @LTxJournal: 🚨Interested in earning MOC?🚨 Check out this paper by Weinberg et al - Multicenter, Double‐Blind, Randomized Trial of Emr…

🚨Interested in earning MOC?🚨 Check out this paper by Weinberg et al - Multicenter, Double‐Blind, Randomized Trial of Emricasan in Hepatitis C–Treated Liver Transplant Recipients w/ Residual Fibrosis or Cirrhosis https://t.co/JgRB9aiF4u #HCV #Hepati…

RT @penngihep: Check out this terrific publication including @penngihep authors: Ethan Weinberg, Rajender Reddy & more esteemed colleagues…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 9 additional X posts.